About Nicholas Downing
Form D filings for Cardurion Pharmaceuticals from 2021 to 2024 list Nicholas Downing as director.
Nicholas Downing first appears on SEC filings in 2021.
Experience
This experience comes from SEC filings. The years are when the filings name Nicholas Downing in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Nicholas Downing works with at each company, as listed on that company's latest Form D.
Cardurion Pharmaceuticals, Inc. · Form D, Jul 24, 2024
ER
Evan Rachlin
Director
Jeb Keiper
Director
MM
Michael Mendelsohn
Executive officer and director
DL
Daniel Lynch
Director
ER
Emma Reeve
Director
PL
Peter Lawrence
President and Chief Executive Officer, director
EM
Edward Mathers
Director
AK
Adam Koppel
Director